M. Thamer

发表

Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis Foundation

L. Melton, L. Melton, N. Ray, 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Fractures Attributable to Osteoporosis: Report from the National Osteoporosis Foundation

T A Einhorn, C C Johnston, S. Silverman, 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Economic Consequences of Diabetes Mellitus in the U.S. in 1997

N. Ray, J. K. Chan, M. Thamer, 1998, Diabetes Care.

Influence of safety warnings on ESA prescribing among dialysis patients using an interrupted time series

D. Lai, M. Thamer, Yi Zhang, 2013, BMC Nephrology.

Influence of the NIH Consensus Conference on Helicobacter pylori on physician prescribing among a Medicaid population.

J. Ferguson, C. Sherman, N. Ray, 1998, Medical care.

U.S. NEPHROLOGISTS’ ATTITUDES TOWARDS RENAL TRANSPLANTATION: RESULTS FROM A NATIONAL SURVEY

N. Powe, R. Brookmeyer, E. Bass, 2001, Transplantation.

Gender Disparities in Vascular Access Surgical Outcomes in Elderly Hemodialysis Patients

M. Allon, M. Thamer, Timmy Lee, 2018, American Journal of Nephrology.

Erythropoiesis-stimulating agent use among non-dialysis-dependent CKD patients before and after the trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) using a large US health plan database.

J. Kaufman, M. Thamer, Yi Zhang, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Major Declines in Epoetin Dosing after Prospective Payment System Based on Dialysis Facility Organizational Status

M. Hernán, J. Kaufman, M. Thamer, 2015, American Journal of Nephrology.

Organizational status of dialysis facilities and patient outcome: does higher injectable medication use mediate increased mortality?

M. Thamer, Yi Zhang, Onkar Kshirsagar, 2013, Health services research.

Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis: the authors respond.

M. Hernán, J. Kaufman, M. Thamer, 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Vascular Access Type and Clinical Outcomes among Elderly Patients on Hemodialysis.

Qian Zhang, M. Allon, M. Thamer, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Dialysis Chains and Placement on the Waiting List for a Cadaveric Kidney Transplant

M. Schlesinger, M. Thamer, Yi Zhang, 2014, Transplantation.

Race/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment

M. Shiffman, R. Wong, M. Thamer, 2018, The American Journal of Gastroenterology.

Evaluation of Health Care Technologies in the United States Compared to Canada and European Countries

S. Perry, M. Thamer, 1999 .

Asthma Hospitalizations Among California Residents Aged 0 to 64 Years in 1993 , by Race / Ethnicity Rate of Asthma Hospitalization

P. Gergen, N. Ray, M. Thamer, 2007 .

The effect of dialysis chains on mortality among patients receiving hemodialysis.

M. Thamer, Yi Zhang, D. Cotter, 2011, Health services research.

Dialysis: Survival and Palliation

M. Thamer, D. Cotter, Mellar P Daviss, 2016 .

Association of Peritonitis with Hemodialysis Catheter Dependence after Modality Switch.

Qian Zhang, M. Allon, M. Thamer, 2016, Clinical journal of the American Society of Nephrology : CJASN.

Does Vascular Access Type Affect Access-Related Costs?

M. Thamer, 2020, Kidney360.

Association between antihypertensive drug use and hypoglycemia: a case-control study of diabetic users of insulin or sulfonylureas.

N. Ray, M. Thamer, T. Taylor, 1999, Clinical therapeutics.

Dialysis in Older Adults: Is Later Start the Preferred Approach?

S. Rosansky, D. Crews, M. Thamer, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Racial Disparities in the Arteriovenous Fistula Care Continuum in Hemodialysis Patients.

M. Allon, D. Crews, M. Thamer, 2020, Clinical journal of the American Society of Nephrology : CJASN.

Tradeoffs in Vascular Access Selection in Elderly Patients Initiating Hemodialysis With a Catheter.

M. Allon, M. Thamer, Timmy Lee, 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Low Rates of Hepatitis B Virus Treatment Among Treatment-Eligible Patients in Safety-Net Health Systems

R. Wong, M. Thamer, Mamta K. Jain, 2021, Journal of clinical gastroenterology.

Has Access to Hepatitis C Virus Therapy Changed for Patients With Mental Health or Substance Use Disorders in the Direct‐Acting‐Antiviral Period?

M. Shiffman, R. Wong, M. Thamer, 2018, Hepatology.

Does dose matter?

M. Thamer, Yi Zhang, D. Cotter, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contributions of related airway illnesses.

P. Gergen, M. Kaliner, J. Baraniuk, 1999, The Journal of allergy and clinical immunology.

A comparison of predialysis estimated glomerular filtration rate in the US, Canada, France, Australia, and the UK between 2005 and 2015.

S. Rosansky, L. Moist, F. Caskey, 2019, Kidney international.

Unequal access to cadaveric kidney transplantation in California based on insurance status.

G. Danovitch, J. Greer, N. Ray, 1999, Health services research.

Hospitalization and expenditures for the treatment of general medical conditions among the U.S. diabetic population in 1991.

R. Ratner, N. Ray, S. Fehrenbach, 1996, The Journal of clinical endocrinology and metabolism.

Long-Term Outcomes of Arteriovenous Fistulas with Unassisted versus Assisted Maturation: A Retrospective National Hemodialysis Cohort Study.

M. Allon, M. Thamer, Timmy Lee, 2019, Journal of the American Society of Nephrology : JASN.

Drug use concomitant with cyclosporine immunosuppressive therapy for 3 years after renal transplantation.

P. Kimmel, J. Vassalotti, N. Ray, 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Medicare Costs Associated With Arteriovenous Fistulas Among US Hemodialysis Patients.

D. Gottlieb, M. Thamer, Timmy Lee, 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Implementing Advance Care Planning for dialysis patients: HIGHway project

M. Unruh, M. Germain, M. Thamer, 2022, BMC Palliative Care.

Sustained Improvements in Markers of Liver Disease Severity After Hepatitis C Treatment.

M. Shiffman, R. Wong, M. Thamer, 2020, Journal of clinical and experimental hepatology.

Public and private health insurance of US foreign-born residents: implications of the 1996 welfare reform law.

M. Thamer, C. Rinehart, 1998, Ethnicity & health.

Anemia management and mortality risk in incident hemodialysis patients.

M. Thamer, Yi Zhang, D. Cotter, 2010, JAMA.

US nephrologists' recommendation of dialysis modality: results of a national survey.

N. Powe, R. Brookmeyer, E. Bass, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The effect of insurance status on use of recombinant erythropoietin therapy among end-stage renal disease patients in three states.

J. Greer, N. Ray, M. Thamer, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Excluded From Universal Coverage: ESRD Patients Not Covered by Medicare

J. Greer, N. Ray, M. Thamer, 1995, Health care financing review.

Medical and Surgical Supply Costs: Case Study of a Costly Low-Cost Technology

S. Perry, M. Thamer, K. Fitzpatrick, 1997, International Journal of Technology Assessment in Health Care.

Improved Survival with Higher Hematocrits: Where is the Evidence?

M. Thamer, Yi Zhang, D. Cotter, 2004, Seminars in dialysis.

Secular trends in recombinant erythropoietin therapy among the U.S. hemodialysis population: 1990-1996.

P. Kimmel, J. Sadler, M. Thamer, 1998, Kidney international.

Use of clinical guidelines for treatment of anemia among hemodialysis patients.

M. Thamer, P. Ivanovich, J. Klinkmann, 2000, Artificial organs.

Racial Disparities in Arteriovenous Fistula Use Among Hemodialysis Patients: The Role of Surgeon Supply

M. Allon, D. Crews, M. Thamer, 2022, Kidney international reports.

Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis.

Yi Zhang, Miguel A Hernán, Dennis Cotter, 2007, JAMA.

Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994.

S. Perry, N. Ray, M. Thamer, 1998, Journal of the American College of Surgeons.

Impact of psychological stress on the oxygen dependency prognosis of hospitalized adult patients with corona virus diseases-19 in respiratory isolation wards: A repeated-measure study

M. Thamer, S. Al-Fayyadh, 2021 .

Healthcare expenditures for sinusitis in 1996: contributions of asthma, rhinitis, and other airway disorders.

P. Gergen, M. Kaliner, J. Baraniuk, 1999, The Journal of allergy and clinical immunology.

Health technology assessment: decentralized and fragmented in the US compared to other countries.

S. Perry, M Thamer, M. Thamer, 1997, Health policy.

Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems

R. Wong, M. Thamer, G. Therapondos, 2021, The American journal of gastroenterology.

Adoption of New Pharmacotherapeutic Regimens: Analysis of Physician Prescribing for Peptic Ulcer Disease

N. Ray, M. Thamer, S. Henderson, 1998 .

Outcomes of Elderly Patients after Predialysis Vascular Access Creation.

Qian Zhang, M. Allon, M. Thamer, 2015, Journal of the American Society of Nephrology : JASN.

M. Hernán, J. Kaufman, M. Thamer, 2014, Journal of endocrinology and diabetes.

High doses of epoetin do not lower mortality and cardiovascular risk among elderly hemodialysis patients with diabetes.

M. Hernán, J. Kaufman, M. Thamer, 2011, Kidney international.

Hematocrit was not validated as a surrogate end point for survival among epoetin-treated hemodialysis patients.

D. Scharfstein, J. Kaufman, M. Thamer, 2004, Journal of clinical epidemiology.

Psychiatric illness in patients with end-stage renal disease.

P. Kimmel, N. Ray, M. Thamer, 1998, The American journal of medicine.

Race, income, urbanicity, and asthma hospitalization in California: a small area analysis.

P. Gergen, N. Ray, M. Thamer, 1998, Chest.

A cross-national comparison of orphan drug policies: implications for the U.S. Orphan Drug Act.

R. Semansky, M. Thamer, N. Brennan, 1998, Journal of health politics, policy and law.

The effect of epoetin dose on hematocrit.

M. Hernán, J. Kaufman, D Cotter, 2008, Kidney international.

Epoetin requirements predict mortality in hemodialysis patients.

J. Kaufman, M. Thamer, Yi Zhang, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Comparing the Effectiveness of Dynamic Treatment Strategies Using Electronic Health Records: An Application of the Parametric g‐Formula to Anemia Management Strategies

Jessica G. Young, M. Hernán, M. Thamer, 2018, Health services research.

Translating epoetin research into practice: the role of government and the use of scientific evidence.

Yi Zhang, Dennis Cotter, Mae Thamer, 2006, Health affairs.

Time to consider the role of epoetin.

M. Thamer, Y. Zhang, 2006, Kidney international.

Are associational studies obfuscating?

M. Thamer, 2004, Kidney international.

Cost-quality trade-offs in dialysis care: a national survey of dialysis facility administrators.

N. Powe, E. Bass, N. Levin, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Prednisone, Lupus Activity, and Permanent Organ Damage

M. Hernán, M. Petri, M. Thamer, 2009, The Journal of Rheumatology.

Comparative Effectiveness of Two Anemia Management Strategies for Complex Elderly Dialysis Patients

M. Hernán, J. Kaufman, M. Thamer, 2014, Medical care.

Estimated effect of epoetin dosage on survival among elderly hemodialysis patients in the United States.

M. Hernán, J. Kaufman, M. Thamer, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Health insurance coverage among foreign-born US residents: the impact of race, ethnicity, and length of residence.

N. Ray, M. Thamer, A. Casebeer, 1997, American journal of public health.

Predicting Early Death Among Elderly Dialysis Patients: Development and Validation of a Risk Score to Assist Shared Decision Making for Dialysis Initiation.

H. Bang, Qian Zhang, J. Kaufman, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Impact of the End Stage Renal Disease Prospective Payment System on the Use of Peritoneal Dialysis

Qian Zhang, M. Thamer, Yi Zhang, 2016, Kidney international reports.

Chronic Liver Disease and Cirrhosis are Associated with Worse Outcomes Following SARS-CoV-2 Infection

R. Wong, M. Thamer, Yi Zhang, 2023, Journal of Clinical and Experimental Hepatology.

Are Fortune 100 companies responsive to chronically ill workers?

M Thamer, M. Thamer, B F Montenegro-Torres, 2001, Health affairs.

Reduced Cardiovascular Mortality Associated with Early Vascular Access Placement in Elderly Patients with Chronic Kidney Disease

Qian Zhang, M. Allon, M. Thamer, 2016, American Journal of Nephrology.

Relative risk and economic consequences of inpatient care among patients with renal failure.

P. Kimmel, N. Ray, S. Fehrenbach, 1996, Journal of the American Society of Nephrology : JASN.

Factors influencing route of administration for epoetin treatment among hemodialysis patients in the United States.

J. Kaufman, M. Thamer, Yi Zhang, 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Developing an Interactive Online Guide to Support the Use of Causal Inference Methods in Comparative Effectiveness Research

Yi Zhang, Miguel A. Hernán, Mae Thamer, 2020 .

Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced Anemia.

Benjamin L. Schooley, M. Dickson, P. Yarnold, 2017, Journal of oncology practice.

The Status of Health Technology Assessment Worldwide: Results of an International Survey

M. Thamer, S. Perry, Eric Gardner, 1997, International Journal of Technology Assessment in Health Care.

Who Is at Risk for New Hepatitis B Infections Among People With HIV?

B. Taylor, M. Thamer, Onkar Kshirsagar, 2023, Open Forum Infectious Diseases.

Medical innovation and the critical role of health technology assessment.

S. Perry, M. Thamer, 1999, JAMA.

Outcomes of Elderly Patients after Predialysis Vascular Access Creation.

Qian Zhang, M. Allon, M. Thamer, 2015, Journal of the American Society of Nephrology : JASN.

Clinical Investigations: AsthmaRace, Income, Urbanicity, and Asthma Hospitalization in California: A Small Area Analysis

P. Gergen, N. Ray, M. Thamer, 1998 .

Public support for policies that would help people with chronic conditions.

W. Hwang, M. Thamer, G. Anderson, 2002, Health affairs.